Immune-modulatory effects of bortezomib in GVHD

Leuk Lymphoma. 2007 May;48(5):853-4. doi: 10.1080/10428190701297394.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Bone Marrow Cells / metabolism
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Cytokines / metabolism
  • Graft vs Host Disease / drug therapy*
  • Humans
  • Immune System / drug effects*
  • Inflammation
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / immunology
  • Multiple Myeloma / therapy
  • NF-kappa B / metabolism
  • Plasmacytoma / drug therapy
  • Pyrazines / therapeutic use*
  • Spleen / cytology
  • Spleen / metabolism
  • Stem Cell Transplantation
  • T-Lymphocytes / metabolism
  • Transplantation, Homologous

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Cytokines
  • NF-kappa B
  • Pyrazines
  • Bortezomib